Resultados de la búsqueda

Domanski MJ, Fuster V, Diaz-Mitoma F, Grundy S, Lloyd-Jones D, Mamdani M, Roberts R, Thorpe K, Hall J, Udell JA, Farkouh ME. Next Steps in Primary Prevention of Coronary Heart Disease: Rationale for and Design of the ECAD Trial. J Am Coll Cardiol (2015) 66:1828-36
Bednarek D, Gonzalez-Rosa JM, Guzman-Martinez G, Gutierrez-Gutierrez O, Aguado T, Sanchez-Ferrer C, Marques IJ, Galardi-Castilla M, de Diego I, Gomez MJ, Cortes A, Zapata A, Jimenez-Borreguero LJ, Mercader N*, Flores I*. (NM and IF are co-corresponding authors) Telomerase Is Essential for Zebrafish Heart Regeneration. Cell Rep (2015) 12:1691-703
Link to the full text in Repisalud
Garcia-Alvarez A, Garcia-Lunar I, Pereda D, Fernandez-Jimenez R, Sanchez-Gonzalez J, Mirelis JG, Nuno-Ayala M, Sanchez-Quintana D, Fernandez-Friera L, Garcia-Ruiz JM, Pizarro G, Aguero J, Campelos P, Castella M, Sabate M, Fuster V, Sanz J, Ibanez B Association of Myocardial T1-Mapping CMR With Hemodynamics and RV Performance in Pulmonary Hypertension JACC Cardiovasc Imaging (2015) 8:76-82
Pozo E, Alvarez-Acosta L, Alonso D, Pazos-Lopez P, de Siqueira ME, Jacobi A, Narula J, Fuster V, Sanz J Diagnostic accuracy of coronary ct for the quantification of the syntax score in patients with left main and/or 3-vessel coronary disease. Comparison with invasive angiography Int J Cardiol (2015) 182:549-56
Castellano JM, Bueno H, Fuster V. The cardiovascular polypill: clinical data and ongoing studies. Int J Cardiol (2015) 201:S8-14
Tamargo J, Castellano JM, Fuster V. The Fuster-CNIC-Ferrer Cardiovascular Polypill: a polypill for secondary cardiovascular prevention. Int J Cardiol (2015) 201:S15-22
Fernandez-Jimenez R, Sanchez-Gonzalez J, Aguero J, Del Trigo M, Galan-Arriola C, Fuster V, Ibanez B. Fast T2 gradient-spin-echo (T2-GraSE) mapping for myocardial edema quantification: first in vivo validation in a porcine model of ischemia/reperfusion. J Cardiovasc Magn Reson (2015) 17:92
Link to the full text in Repisalud
Mingo-Santos S, Monivas-Palomero V, Garcia-Lunar I, Mitroi CD, Goirigolzarri-Artaza J, Rivero B, Oteo JF, Castedo E, Gonzalez-Mirelis J, Cavero MA, Gomez-Bueno M, Segovia J, Alonso-Pulpon L. Mingo-Santos S, Monivas-Palomero V, Garcia-Lunar I, Mitroi CD, Goirigolzarri-Artaza J, Rivero B, Oteo JF, Castedo E, Gonzalez-Mirelis J, Cavero MA, Gomez-Bueno M, Segovia J, Alonso-Pulpon L. J Am Soc Echocardiog (2015) 28:1149-56
Laclaustra M, Hurtado-Roca Y, Sendin M, Leon M, Ledesma M, Andres E, Fernandez-Ortiz A, Guallar E, Ordovas JM, Casasnovas JA. Lower-normal TSH is associated with better metabolic risk factors: A cross-sectional study on Spanish men. Nutr Metab Cardiovasc Dis (2015) 25:1095-103

Pages